REATA PHARMACEUTICALS INC Quarterly Income Tax Expense (Benefit) in USD from Q1 2015 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Reata Pharmaceuticals Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2015 to Q2 2023.
  • Reata Pharmaceuticals Inc Income Tax Expense (Benefit) for the quarter ending June 30, 2023 was $0.000.
  • Reata Pharmaceuticals Inc Income Tax Expense (Benefit) for the twelve months ending June 30, 2023 was -$55K, a 122% decline year-over-year.
  • Reata Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2022 was -$25K, a 94.4% increase from 2021.
  • Reata Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2021 was -$450K, a 98% increase from 2020.
  • Reata Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2020 was -$22.5M, a 281188% decline from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$55K $0 +$1K Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$56K $0 -$31K -100% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q4 2022 -$25K -$55K -$273K -125% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-24
Q3 2022 $248K $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $248K -$1K +$652K +99.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$404K $31K +$46K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$450K $218K +$369K Oct 1, 2021 Dec 31, 2021 10-K 2023-02-24
Q3 2021 -$819K $0 +$93K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$912K -$653K -$650K -21667% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$262K -$15K +$22.2M +99.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$22.5M -$151K -$99K -190% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-01
Q3 2020 -$22.4M -$93K -$131K -345% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$22.3M -$3K -$23K -115% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$22.2M -$22.2M* -$22.2M -1112100% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $8K -$52K -$63K -573% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 $71K $38K +$29K +322% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-01
Q2 2019 $42K $20K +$14K +233% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-01
Q1 2019 $28K $2K Jan 1, 2019 Mar 31, 2019 10-K 2021-03-01
Q4 2018 $11K Oct 1, 2018 Dec 31, 2018 10-K 2020-02-19
Q3 2018 $9K +$8K +800% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-19
Q2 2018 $6K +$4K +200% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-19
Q3 2017 $1K $0 0% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 $2K +$463K Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q4 2016 -$441K $1K -$1.19M -99.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-02
Q3 2016 $750K $1K +$141K Jul 1, 2016 Sep 30, 2016 10-K 2018-03-02
Q2 2016 $609K -$461K -$943K -196% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-02
Q1 2016 $1.55M $18K +$404K Jan 1, 2016 Mar 31, 2016 10-K 2018-03-02
Q4 2015 $1.15M $1.19M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-03
Q3 2015 -$140K Jul 1, 2015 Sep 30, 2015 10-K 2017-03-03
Q2 2015 $482K Apr 1, 2015 Jun 30, 2015 10-K 2017-03-03
Q1 2015 -$386K Jan 1, 2015 Mar 31, 2015 10-K 2017-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.